MX350814B - Producto y metodo para tratar diarrea. - Google Patents

Producto y metodo para tratar diarrea.

Info

Publication number
MX350814B
MX350814B MX2015011885A MX2015011885A MX350814B MX 350814 B MX350814 B MX 350814B MX 2015011885 A MX2015011885 A MX 2015011885A MX 2015011885 A MX2015011885 A MX 2015011885A MX 350814 B MX350814 B MX 350814B
Authority
MX
Mexico
Prior art keywords
product
treating diarrhea
receptor antagonist
diarrhea
treating
Prior art date
Application number
MX2015011885A
Other languages
English (en)
Other versions
MX2015011885A (es
Inventor
B Hogan Ii Reed
Original Assignee
Maregade Rx Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maregade Rx Llc filed Critical Maregade Rx Llc
Publication of MX2015011885A publication Critical patent/MX2015011885A/es
Publication of MX350814B publication Critical patent/MX350814B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se describe un método para tratar diarrea en un paciente, el cual consiste en administrar al paciente un antagonista del receptor H1 y un antagonista del receptor H2.
MX2015011885A 2013-03-14 2014-03-14 Producto y metodo para tratar diarrea. MX350814B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361782608P 2013-03-14 2013-03-14
PCT/US2014/027323 WO2014152420A2 (en) 2013-03-14 2014-03-14 Product and method for treating diarrhea

Publications (2)

Publication Number Publication Date
MX2015011885A MX2015011885A (es) 2016-05-16
MX350814B true MX350814B (es) 2017-09-21

Family

ID=50680150

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015011885A MX350814B (es) 2013-03-14 2014-03-14 Producto y metodo para tratar diarrea.
MX2017011532A MX366329B (es) 2013-03-14 2014-03-14 Producto y metodo para tratar diarrea.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2017011532A MX366329B (es) 2013-03-14 2014-03-14 Producto y metodo para tratar diarrea.

Country Status (20)

Country Link
US (4) US9717726B2 (es)
EP (3) EP3269364B1 (es)
JP (4) JP6313417B2 (es)
KR (4) KR20200100211A (es)
CN (2) CN108939076A (es)
AU (3) AU2014239878B2 (es)
BR (2) BR122017004716A2 (es)
CA (1) CA2906005C (es)
DK (1) DK2968205T3 (es)
ES (2) ES2743604T3 (es)
HK (2) HK1213205A1 (es)
HU (1) HUE035201T2 (es)
IL (3) IL273377B2 (es)
MX (2) MX350814B (es)
MY (1) MY175326A (es)
PL (1) PL2968205T3 (es)
PT (1) PT2968205T (es)
RU (1) RU2015143475A (es)
WO (1) WO2014152420A2 (es)
ZA (1) ZA201708539B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9717726B2 (en) * 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
US20150132410A1 (en) * 2013-11-14 2015-05-14 Michael M. Jacobs Compositions and methods for the prevention and treatment of alcohol-induced hangover syndrome
ES2953520T3 (es) 2016-12-23 2023-11-14 Maregade Rx Llc Producto a baja dosis y método para el tratamiento de la diarrea
IT201900012645A1 (it) * 2019-07-23 2021-01-23 Eros Zanotti Una composizione farmaceutica per l'uso nel trattamento delle chinetosi
WO2020100357A1 (ja) * 2019-08-05 2020-05-22 株式会社日立ハイテク プラズマ処理装置
CA3233054A1 (en) * 2021-09-22 2023-03-30 Hista Rx Llc Compositions and methods for treating and preventing interstitial cystitis

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204118A (en) 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
AU7255094A (en) 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-antihistamine combinations
US6264984B1 (en) * 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
US6656492B2 (en) * 2000-06-30 2003-12-02 Yamanouchi Pharmaceutical Co., Ltd. Quick disintegrating tablet in buccal cavity and manufacturing method thereof
CA2430292A1 (en) 2000-11-30 2002-06-06 The Bio Balance Corp. Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
PL209953B1 (pl) * 2001-11-23 2011-11-30 Janssen Pharmaceutica Nv Zastosowanie pochodnej benzimidazo [2,1-b] [3] benzazepiny
SE528789C2 (sv) 2004-09-10 2007-02-13 Sandvik Intellectual Property PVD-belagt skär av hårdmetall samt sätt att tillverka detta
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
WO2007111945A2 (en) 2006-03-22 2007-10-04 Trustees Of Boston University Method for management of diarrhea
US8207188B2 (en) 2006-04-07 2012-06-26 Michalis Nicolaou Treatment of diseases modulated by a H4 receptor agonist
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US20090042972A1 (en) * 2006-05-19 2009-02-12 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
EP2170317A4 (en) 2007-02-12 2011-03-23 Mike Nicolaou TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), GASTRO-OESOPHAGEAL REFLUX DISEASE (GERD), FOOD ALLERGIES, AND OTHER DISEASES AND GASTROINTESTIN DISORDERS AFFECTED BY APPROPRIATE MANAGEMENT OF HISTAMINE USING A COMBINATION OF INHIBITORS HISTIDINE DECARBOXYLASE, MEDICAMEN
EP2148659A2 (en) * 2007-04-13 2010-02-03 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
CN105051192B (zh) 2012-11-13 2020-04-17 科迪艾克生物科学公司 治疗剂的递送
US9717726B2 (en) * 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
ES2953520T3 (es) 2016-12-23 2023-11-14 Maregade Rx Llc Producto a baja dosis y método para el tratamiento de la diarrea

Also Published As

Publication number Publication date
KR20200100211A (ko) 2020-08-25
MX2015011885A (es) 2016-05-16
JP6473254B2 (ja) 2019-02-20
AU2017251701A1 (en) 2017-11-09
EP3581205A2 (en) 2019-12-18
US20140275116A1 (en) 2014-09-18
PT2968205T (pt) 2018-01-05
AU2017251701B2 (en) 2019-03-14
AU2014239878A1 (en) 2015-10-15
US9717726B2 (en) 2017-08-01
ES2743604T3 (es) 2020-02-20
BR122017004716A2 (pt) 2019-07-30
AU2014239878B2 (en) 2017-08-24
BR112015022513A2 (pt) 2017-07-18
KR20150139535A (ko) 2015-12-11
JP2019089796A (ja) 2019-06-13
MX366329B (es) 2019-07-05
US20170049770A1 (en) 2017-02-23
MY175326A (en) 2020-06-19
IL273377B2 (en) 2023-10-01
JP6313417B2 (ja) 2018-04-18
EP3269364A1 (en) 2018-01-17
CN105324112B (zh) 2018-08-17
ES2655505T3 (es) 2018-02-20
IL273377B1 (en) 2023-06-01
KR102449977B1 (ko) 2022-09-30
EP2968205A2 (en) 2016-01-20
KR20180088514A (ko) 2018-08-03
HK1213205A1 (zh) 2016-06-30
IL241372B (en) 2018-06-28
IL241372A0 (en) 2015-11-30
WO2014152420A2 (en) 2014-09-25
EP3269364B1 (en) 2019-05-29
ZA201708539B (en) 2019-05-29
CA2906005C (en) 2021-12-28
WO2014152420A3 (en) 2014-11-20
CN105324112A (zh) 2016-02-10
AU2019201412A1 (en) 2019-03-21
US10034875B2 (en) 2018-07-31
HUE035201T2 (hu) 2018-05-02
RU2015143475A (ru) 2017-04-20
JP2016513692A (ja) 2016-05-16
EP2968205B1 (en) 2017-10-11
IL273377A (en) 2020-05-31
KR101884506B1 (ko) 2018-08-01
EP3581205A3 (en) 2020-03-25
US20220047583A1 (en) 2022-02-17
IL256300A (en) 2018-02-28
JP2021046400A (ja) 2021-03-25
KR20210021606A (ko) 2021-02-26
JP2018135340A (ja) 2018-08-30
PL2968205T3 (pl) 2018-03-30
JP6790140B2 (ja) 2020-11-25
CN108939076A (zh) 2018-12-07
CA2906005A1 (en) 2014-09-25
HK1247557B (zh) 2020-07-03
US20190038619A1 (en) 2019-02-07
US11058681B2 (en) 2021-07-13
DK2968205T3 (da) 2017-11-27
IL256300B (en) 2020-04-30

Similar Documents

Publication Publication Date Title
MX2015009106A (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
AU357122S (en) Headgear for patient interface
EP2989047A4 (en) METHOD AND GENERATOR FOR THE PRODUCTION OF HYDROGEN
AU355322S (en) Chair
MY175326A (en) Product and method for treating diarrhea
SA516370641B1 (ar) مركبات حلقية غير متجانسة وطرق لاستخدامها
GB201306350D0 (en) Apparatus and methods for key generation
EP2968345A4 (en) DOUBLE MEK / PI3K INHIBITORS AND THERAPEUTIC PROCESSES USING SAME
EP2983625C0 (en) SELF-CLOSING DEVICES AND APPARATUS AND THEIR MANUFACTURING AND INSTALLATION PROCESSES
SG11201604626VA (en) Medicament apparatus and method
EP2948669A4 (en) FUEL TREATMENT APPARATUS
AU350280S (en) Apparatus for skin treatment
GB2526490B (en) Feed delivery system and method for gasifier
MX2015013021A (es) 5-bromo-indirrubinas.
PH12017500923A1 (en) New dosage and use of a a2a antagonist
MX368870B (es) Uso de un antagonista de receptores de opioides con actividad kappa y vortioxetina para el tratamiento de trastorno depresivo con características melancólicas.
IL248962A0 (en) Device and method for administering drugs to the brain
MX2016016667A (es) Métodos para tratar el cáncer y prevenir la resistencia a fármacos contra el cáncer.
EP3080246A4 (en) Compositions and methods for producing and administering brown adipocytes
IN2013MU01111A (es)
EP2916238A4 (en) CORPUS CREATIVE DEVICE, CORPUSED CREATION PROCESS AND CORPUSED CREATING PROGRAM
MX2016011706A (es) Formulaciones de progesterona.
NZ631749A (en) Methods of treating cancer using angiogenin or an angiogenin agonist
SG11201808894RA (en) Injection device
SG2013064043A (en) Process and apparatus for generating hydrogen

Legal Events

Date Code Title Description
FG Grant or registration